Progressive multifocal leukoencephalopathy (PML) after transplantation

@article{Nguyen2011ProgressiveML,
  title={Progressive multifocal leukoencephalopathy (PML) after transplantation},
  author={C. Nguyen and R. Shapiro},
  journal={Pediatric Transplantation},
  year={2011},
  volume={15}
}
Progressive multifocal leukoencephalopathy (PML) is a rare and often fatal opportunistic demyelinating disorder related to a viral infection of the central nervous system that was initially described in immunocompromised patients. It has commonly been reported in patients with hematologic malignancies, systemic lupus erythematosus, and chronic inflammatory diseases and is recognized as an AIDS-defining illness. No effective treatment is available at present for PML, and the article by Weber et… Expand
2 Citations
Progressive multifocal leukoencephalopathy presenting with acute sensorineural hearing loss in an intestinal transplant recipient
TLDR
This case highlights progressive multifocal leukoencephalopathy (PML) as a rare complication after solid organ transplantation and acute sensorineural hearing loss as an unusual first presenting symptom of PML. Expand
Primary infection with human herpes virus type 6, post‐pediatric liver transplantation—A pathogen to remember
TLDR
In recent years, liver transplantation has become a well‐accepted therapeutic modality for children with end‐stage liver disease, with transplantation surgery being performed at a younger age, and data on primary HHV‐6 infection in pediatric liver transplant recipients is scarce. Expand

References

SHOWING 1-10 OF 10 REFERENCES
Progressive multifocal leukoencephalopathy in transplant recipients
TLDR
Progressive multifocal leukoencephalopathy is a unique entity that should be considered in any transplant recipient with neurological symptoms and is usually fatal, although regression has been reported. Expand
Progressive multifocal leukoencephalopathy: Can we reduce risk in patients receiving biological immunomodulatory therapies?
TLDR
In the case of extraneural reactivation, JCV-infected B cells could provide a mechanism for virus transmigration across the blood-brain barrier, with infection of cerebral microvascular endothelial cells by cell-free blood-borne virus providing an alternative route. Expand
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation.
TLDR
There was no significant association between PML and MMF, but MMF use in this cohort is too high to accurately assess an association, and PML is rare in the renal transplant population. Expand
Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation
TLDR
This review focuses on the biologics in current use in CD (infliximab, adalimumab, and natalizumab), in order to provide a reference and gateway to prevention, recognition, and management of JCV, in the early years of biological agents therapy. Expand
Cytokine production by activated T cells in common variable immunodeficiency.
TLDR
This study indicates that some CVID patients have T-cell proliferation and secretory defects and that these may be associated with severe manifestations of disease. Expand
Progressive multifocal leukoencephalopathy: Can we reduce risk in patients receiving biological immunomodulatory therapies? [Electronic version
  • Ann Neurol
  • 2010
Primary antibody deficiency syndromes. [Electronic version
  • Ann Clin Biochem
  • 2009
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. [Electronic version
  • Transplantation
  • 2008
Electronic Version
Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney
  • transplantation